Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) dysregulation in human malignant meningiomas

Oncogene

Volumn 32, Issue 10, 2013, Pages 1216-1222

  Liu, Z Y ^a   Wang, J Y ^a   Liu, H H ^a   Ma, X M ^a   Wang, C L ^a,b   Zhang, X P ^c   Tao, Y Q ^a   Lu, Y C ^a   Liao, J C ^a   Hu, G H ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Department of Neurosurgery ^*  (China)

^c SHANGHAI UNIVERSITY OF MEDICINE AND HEALTH SCIENCES   (China)

Author keywords

apoptosis; malignant; meningiomas; retinoblastoma protein interacting zinc finger gene 1 (RIZ1); tumor suppressor gene

Indexed keywords

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL ASSAY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; M PHASE CELL CYCLE CHECKPOINT; MALIGNANT MENINGIOMA; MICROARRAY ANALYSIS; MITOSIS INHIBITION; ONCOGENE C MYC; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETINOBLASTOMA PROTEIN INTERACTING ZINC FINGER GENE 1; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; MENINGIOMA; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; ZINC FINGERS;

LENTIVIRUS;

EID: 84874764746     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.155     Document Type: Article

References (27)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97-109.
2. Glaholm J, Bloom HJ, Crow JH. The role of radiotherapy in the management of intracranial meningiomas: the Royal Marsden Hospital experience with 186 patients. Int J Radiat Oncol Biol Phys 1990; 18: 755-761.
3. Goldsmith BJ, Wara WM, Wilson CB, Larson DA. Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 1994; 80: 195-201.
4. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC. 'Malignancy' in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 1999; 85: 2046-2056.
5. Ware ML, Larson DA, Sneed PK, Wara WW, McDermott MW. Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma. Neurosurgery 2004; 54: 55-63.
6. Carling T, Kim KC, Yang XH, Gu J, Zhang XK, Huang S. A histone methyltransferase is required for maximal response to female sex hormones. Mol Cell Biol 2004; 24: 7032-7042.
7. Buyse IM, Shao G, Huang S. The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein. Proc Natl Acad Sci USA 1995; 92: 4467-4471.
8. Huang S, Shao G, Liu L. The PR domain of the Rb-binding zinc finger protein RIZ1 is a protein binding interface and is related to the SET domain functioning in chromatin-mediated gene expression. J Biol Chem 1998; 273: 15933-15939.
9. Liu L, Shao G, Steele-Perkins G, Huang S. The retinoblastoma interacting zinc finger gene RIZ produces a PR domain-lacking product through an internal promoter. J Biol Chem 1997; 272: 2984-2991.
10. Rea S, Eisenhaber F, O'Carroll D, Strahl BD, Sun ZW, Schmid M et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 2000; 406: 593-599.
11. Chadwick RB, Jiang GL, Bennington GA, Yuan B, Johnson CK, Stevens MW et al. Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis. Proc Natl Acad Sci USA 2000; 97: 2662-2667.
12. He L, Yu JX, Liu L, Buyse IM, Wang MS, Yang QC et al. RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res 1998; 58: 4238-4244.
13. Jiang G, Liu L, Buyse IM, Simon D, Huang S. Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of hepatoma tumorigenicity by RIZ1. Int J Cancer 1999; 83: 541-546.
14. Steele-Perkins G, Fang W, Yang XH, Van Gele M, Carling T, Gu J et al. Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear proteinmethyltransferase superfamily. Genes Dev 2001; 15: 2250-2262.
15. Piao Z, Fang W, Malkhosyan S, Kim H, Horii A, Perucho M et al. Frequent frameshift mutations of RIZ in sporadic gastrointestinal and endometrial carcinomas with microsatellite instability. Cancer Res 2000; 60: 4701-4704.
16. Jiang GL, Huang S. Adenovirus expressing RIZ1 in tumor suppressor gene therapy of microsatellite-unstable colorectal cancers. Cancer Res 2001; 61: 1796-1798.
17. Tao Y, Wei Q, Xu Z, Bai R, Li Y, Luo C et al. Holistic and network analysis of meningioma pathogenesis and malignancy. Biofactors 2006; 28: 203-219.
18. Rossi V, Staibano S, Abbondanza C, Pasquali D, De Rosa C, Mascolo M et al. Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2. J Cell Physiol 2009; 221: 771-777.
19. Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou Y et al. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res 2010; 70: 2350-2358.
20. Modha A, Gutin PH. Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 2005; 57: 538-550.
21. Weber RG, Bostrom J, Wolter M, Baudis M, Collins VP, Reifenberger G et al. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 1997; 94: 14719-14724.
22. Shadat NM, Koide N, Khuda, Dagvadorj J, Tumurkhuu G, Naiki Y et al. Retinoblastoma protein interacting zinc finger 1 (RIZ1) regulates the proliferation of monocytic leukemia cells via activation of p53. Cancer Invest 2001; 28: 806-812.
23. Gazzerro P, Abbondanza C, D'Arcangelo A, Rossi M, Medici N, Moncharmont B et al. Modulation of RIZ gene expression is associated to estradiol control of MCF- 7 breast cancer cell proliferation. Exp Cell Res 2006; 312: 340-349.
24. Lee WH. Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee. Neurosurgery 1990; 27: 389-395.
25. Kim Y, Shintani S, Kohno Y, Zhang R, Wong DT. Cyclin G2 dysregulation in human oral cancer. Cancer Res 2004; 64: 8980-8986.
26. Zhang X, Sun H, Danila DC, Johnson SR, Zhou Y, Swearingen B et al. Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis. J Clin Endocrinol Metab 2002; 87: 1262-1267.
27. Wang J, Wang Q, Cui Y, Liu ZY, Zhao W, Wang CL et al. Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells. J Neurooncol 2012; 106: 473-484.